BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lorito N, Bacci M, Smiriglia A, Mannelli M, Parri M, Comito G, Ippolito L, Giannoni E, Bonechi M, Benelli M, Migliaccio I, Malorni L, Chiarugi P, Morandi A. Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib.. Cells 2020;9:E668. [PMID: 32164162 DOI: 10.3390/cells9030668] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Ma J, Zhao W, Zhang H, Chu Z, Liu H, Fang X, Tang D. Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis. Life Sci 2022;306:120810. [PMID: 35850243 DOI: 10.1016/j.lfs.2022.120810] [Reference Citation Analysis]
2 Zhou D, Yu X, Song Y, Zeng H, Zhang H, Chen B, Wang Y, Li H, Liu X, He Q, Li X, Zhou W. Screening of and mechanism underlying the action of serum- and glucocorticoid-regulated kinase 3-targeted drugs against estrogen receptor-positive breast cancer. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174982] [Reference Citation Analysis]
3 Fujii T, Kamishikiryo J, Morita T. Palbociclib regulates intracellular lipids in mammary tumor cells by secreting lipoprotein lipase. Pharmacol Rep. [DOI: 10.1007/s43440-022-00365-0] [Reference Citation Analysis]
4 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ripoll C, Roldan M, Ruedas-Rama MJ, Orte A, Martin M. Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification. Biology (Basel) 2021;10:1267. [PMID: 34943182 DOI: 10.3390/biology10121267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fontana F, Limonta P. The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer. Free Radic Biol Med 2021;176:203-21. [PMID: 34597798 DOI: 10.1016/j.freeradbiomed.2021.09.024] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
7 Hussein S, Khanna P, Yunus N, Gatza ML. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. Cancers (Basel) 2021;13:4808. [PMID: 34638293 DOI: 10.3390/cancers13194808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Y, Zhou Q, Song S, Tang S. Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses. Trends Endocrinol Metab 2021:S1043-2760(21)00154-5. [PMID: 34340886 DOI: 10.1016/j.tem.2021.07.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Chiaradonna F, Scumaci D. Cancer Metabolism as a New Real Target in Tumor Therapy. Cells 2021;10:1393. [PMID: 34198722 DOI: 10.3390/cells10061393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Qiu J, Zheng Q, Meng X. Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response. Front Oncol 2021;11:628359. [PMID: 33718202 DOI: 10.3389/fonc.2021.628359] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
11 De Luca M, Romano R, Bucci C. Role of the V1G1 subunit of V-ATPase in breast cancer cell migration. Sci Rep 2021;11:4615. [PMID: 33633298 DOI: 10.1038/s41598-021-84222-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lanceta L, Lypova N, O'Neill C, Li X, Rouchka E, Chesney J, Imbert-Fernandez Y. Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq. Breast Cancer Res Treat 2021;186:677-86. [PMID: 33599863 DOI: 10.1007/s10549-021-06127-5] [Reference Citation Analysis]
13 Marcucci F, Rumio C. Glycolysis-induced drug resistance in tumors-A response to danger signals? Neoplasia 2021;23:234-45. [PMID: 33418276 DOI: 10.1016/j.neo.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang B, Li D, Jin X, Zhang K. The CDK4/6 inhibitor PD0332991 stabilizes FBP1 by repressing MAGED1 expression in pancreatic ductal adenocarcinoma. The International Journal of Biochemistry & Cell Biology 2020;128:105859. [DOI: 10.1016/j.biocel.2020.105859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Luti S, Fiaschi T, Magherini F, Modesti PA, Piomboni P, Governini L, Luddi A, Amoresano A, Illiano A, Pinto G, Modesti A, Gamberi T. Relationship between the metabolic and lipid profile in follicular fluid of women undergoing in vitro fertilization. Mol Reprod Dev 2020;87:986-97. [PMID: 32885549 DOI: 10.1002/mrd.23415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Varghese E, Samuel SM, Líšková A, Samec M, Kubatka P, Büsselberg D. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. Cancers (Basel) 2020;12:E2252. [PMID: 32806533 DOI: 10.3390/cancers12082252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
17 Lanceta L, O'Neill C, Lypova N, Li X, Rouchka E, Waigel S, Gomez-Gutierrez JG, Chesney J, Imbert-Fernandez Y. Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells. Genes (Basel) 2020;11:E467. [PMID: 32344635 DOI: 10.3390/genes11040467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]